Interview: Decentralized Trials with Alethea Wieland

In this interview, Alethea Wieland discusses the transformative impact of decentralized trials on the life sciences industry. Discover the benefits of decentralized trials, including increased efficiency, patient participation, and data accuracy. Alethea addresses regulatory considerations and privacy concerns associated with decentralized trials. Gain valuable insights into the future of clinical research and the exciting possibilities offered by decentralized approaches.